These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34144077)

  • 21. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
    Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
    Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short term visual and structural outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment delay during the first COVID-19 wave: A pilot study.
    Naravane AV; Mundae R; Zhou Y; Santilli C; van Kuijk FJGM; Nazari H; Yamanuha J; Emerson GG; Koozekanani DD; Montezuma SR
    PLoS One; 2021; 16(2):e0247161. PubMed ID: 33596257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.
    Zhou S; Gao J; Xu X
    Clin Exp Ophthalmol; 2014; 42(7):637-49. PubMed ID: 24330277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal injections during COVID-19 outbreak: Real-world experience from an Italian tertiary referral center.
    Carnevali A; Giannaccare G; Gatti V; Scuteri G; Randazzo G; Scorcia V
    Eur J Ophthalmol; 2021 Jan; 31(1):10-12. PubMed ID: 32967465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying metamorphopsia in patients with diabetic macular oedema and other macular abnormalities.
    Achiron A; Lagstein O; Glick M; Gur Z; Bartov E; Burgansky-Eliash Z
    Acta Ophthalmol; 2015 Dec; 93(8):e649-53. PubMed ID: 25899144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the Use of Anti-VEGF Intravitreal Therapies for Retinal Vein Occlusions.
    Jiang Y; Mieler WF
    Asia Pac J Ophthalmol (Phila); 2017; 6(6):546-553. PubMed ID: 29204993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF inhibitors for AMD and diabetic macular edema.
    Med Lett Drugs Ther; 2015 Mar; 57(1464):41-2. PubMed ID: 25758545
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure.
    Nariani A; Williams B; Hariprasad SM
    Indian J Ophthalmol; 2016 Sep; 64(9):643-647. PubMed ID: 27853011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IMPACT OF CORONAVIRUS DISEASE PANDEMIC ON INTRAVITREAL INJECTIONS TREATMENT FOR MACULAR DISEASES: Report From a Referral Hospital in Milan.
    Viola F; Milella P; Pozzo Giuffrida F; Ganci S; Invernizzi A
    Retina; 2021 Apr; 41(4):701-705. PubMed ID: 32796445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study.
    Cho H; Choi KS; Lee JY; Lee D; Choi NK; Lee Y; Bae S
    BMJ Open; 2019 Sep; 9(9):e030930. PubMed ID: 31542758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV; Maltsev DS
    Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.
    Pham B; Thomas SM; Lillie E; Lee T; Hamid J; Richter T; Janoudi G; Agarwal A; Sharpe JP; Scott A; Warren R; Brahmbhatt R; Macdonald E; Straus SE; Tricco AC
    BMJ Open; 2019 May; 9(5):e022031. PubMed ID: 31142516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: a systematic review and meta-analysis.
    Low A; Faridi A; Bhavsar KV; Cockerham GC; Freeman M; Fu R; Paynter R; Kondo K; Kansagara D
    Br J Ophthalmol; 2019 Apr; 103(4):442-451. PubMed ID: 30409915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medications.
    Blaha GR; Brooks NO; Mackel CE; Pani A; Stewart AP; Price LL; Barouch FC; Chang J; Marx JL
    Retina; 2015 Mar; 35(3):577-81. PubMed ID: 25158942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV.
    Wecker T; Ehlken C; Bühler A; Lange C; Agostini H; Böhringer D; Stahl A
    Br J Ophthalmol; 2017 Mar; 101(3):353-359. PubMed ID: 27215744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy.
    Chen YY; Chou P; Huang YF; Chien HJ; Wu YC; Lee CC; Huang LY; Chen HH
    BMC Ophthalmol; 2019 Dec; 19(1):268. PubMed ID: 31888553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept.
    Liu H; Ma Y; Xu HC; Huang LY; Zhai LY; Zhang XR
    Curr Eye Res; 2020 Dec; 45(12):1467-1476. PubMed ID: 32631094
    [No Abstract]   [Full Text] [Related]  

  • 39. Appointment Compliance in Patients With Diabetic Macular Edema and Exudative Macular Degeneration.
    Jansen ME; Krambeer CJ; Kermany DS; Waters JN; Tie W; Bahadorani S; Singer J; Comstock JM; Wannamaker KW; Singer MA;
    Ophthalmic Surg Lasers Imaging Retina; 2018 Mar; 49(3):186-190. PubMed ID: 29554386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.
    Campochiaro PA; Hafiz G; Channa R; Shah SM; Nguyen QD; Ying H; Do DV; Zimmer-Galler I; Solomon SD; Sung JU; Syed B
    Ophthalmology; 2010 Dec; 117(12):2387-2394.e1-5. PubMed ID: 20630595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.